Navigation Links
RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership

FORT WASHINGTON, Pa., July 20, 2011 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), a next generation CRO that provides comprehensive global Phase II-IV clinical development solutions to the biopharmaceutical and medical device industries, today announced the following key additions to its Operational and Senior Management team.  

  • John K. Davis, II, as Chief Information Officer and Executive Vice President, Clinical Systems
  • Martine Dehlinger-Kremer, Ph.D. as Vice President, Global Regulatory Affairs
  • Debra Marshall as Vice President, Clinical Programs and Global Site Management
  • Lexy Kelley, MD as Medical Director, Immunology Development Services
  • Peggy Doran as Executive Director, R&D Business Operations Management

"RPS is extremely pleased to add such a talented and experienced team to our organization," said Harris Koffer, Pharm.D., President and COO.  "These additions will further strengthen our position as an innovator and leading provider of Embedded and Full-Service clinical development solutions in support of our clients expanding global product development needs."

John K. Davis, II brings more than 30 years of experience as an accomplished CIO and operations executive.  He previously served as Senior Vice President and Chief Information Officer at the American Board of Internal Medicine (ABIM) and Executive Vice President and CIO at Omnicare Clinical Research, where he led the globalization of the Clinical Data Management, Biostatistics, Information Technology, Clinical Writing, and Training functions.  

Martine Dehlinger-Kremer, Ph.D. has over 24 years of experience in the pharmaceutical industry with extensive expertise in global Regulatory Affairs.  She most recently served as the Vice President of Global Regulatory Affairs and Global Medical Affairs at Theorem Clinical Research (previously Omnicare Clinical Research). 

Debra Marshall has over 30 years of healthcare and pharmaceutical industry management experience and most recent served as Assistant Vice President, US Global Site Management for Pfizer (formerly Wyeth), where she was instrumental in building a high performing Site Management Organization and implementing enhanced Site Management strategies.

Lexy Kelley, MD brings strong experience in the design, implementation and medical oversight of clinical development programs for the treatment of Lupus as well as clinical research experience in hematology, infectious diseases, rheumatology and allergy.  Prior to joining RPS, she served as an Associate Medical Director at UCB Pharma.

Marguerite (Peggy) Doran has over 25 years of pharmaceutical industry experience, including 18 years of experience in contract negotiation and management, implementation of sourcing strategies, contract optimization and process improvements as well as vendor relationship management and governance programs.

"Because of our unique business model, RPS has achieved impressive growth rates that far exceed those in the late stage CRO marketplace," said Daniel M. Perlman, Chairman and CEO.  "The new additions to our organization are a key component of our continued focus on growth and innovation in support of the global biopharmaceutical and medical device industries."

About RPS

RPS provides comprehensive global Phase II-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries.  By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.

With more than 3,000 employees, RPS operates in 45 countries across the globe.

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Beardsworth Continues to Strengthen Oncology Operations
2. SeqWright Continues Expansion of Next-Generation Sequencing Capabilities
3. Fourth Annual Probiotics Grant Continues to Fuel Growth In Research
4. IGEN Networks Corp continues to build a world class advisory board, with the appointment of three new members
5. Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation
6. New Test Centre in India: TUV Rheinland Continues Worldwide Investment Programme for Solar Industry
7. Simbionix Continues its Global Expansion
8. O2h Continues to Support Senexis to Support Patent Filing Senexis Limited
9. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
10. NEVO(TM) Sirolimus-Eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
11. Dehaier Medical Systems Continues Product Line Expansion. Signs Exclusive Distribution Agreement with HEYER Medical for Respiratory Products in China
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... 2015 In the present market scenario, security ... various industry verticals such as banking, healthcare, defense, electronic ... demand for secure & simplified access control and growing ... hacking of bank accounts, misuse of users, , and ... PC,s, laptops, and smartphones are expected to provide potential ...
Breaking Biology News(10 mins):